New Key Statistics Module, Z-Score and F-Score
NYSE:DNA Key Ratios
Market Cap $ M | 2,367.64 |
Enterprise Value $ M | 1,600.76 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.00 |
Price/Sales | 8.45 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 251.00 |
EPS (TTM) $ | -0.47 |
Beneish M-Score | -4.42 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.77 |
EV-to-EBITDA | -1.92 |
PEG | -- |
Shares Outstanding M | 2,152.40 |
Net Margin (%) | -355.08 |
Operating Margin % | -305.50 |
Pre-tax Margin (%) | -355.11 |
Quick Ratio | 6.11 |
Current Ratio | 6.11 |
ROA % (ttm) | -40.81 |
ROE % (ttm) | -62.03 |
ROIC % (ttm) | -74.22 |
Dividend Yield % | -- |
Altman Z-Score | -2.98 |
Piotroski F-Score | 4.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | N |
DNA Number of Guru Trades
DNA Volume of Guru Trades
Gurus Latest Trades with NYSE:DNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:DNA is held by these investors
Total 1
Ginkgo Bioworks Holdings Inc Insider Transactions
No Available Data
News about NYSE:DNA
Total 0- 1